Destiny 2’s pinnacle PVP activity, Trials of Osiris, returns yet again. If you want to know what this week’s featured map and weapon are, we have all that and more in this breakdown of the ...

Six weeks after Microsoft yanked its £1/$1 Game Pass trial in the run-up to Call of Duty: Black Ops 6's release, the deal has now been reinstated as part of the company's Black Friday and Cyber ...

The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.

The New York Times published the court system’s transcripts from the Manhattan criminal trial of Donald J. Trump, who was charged with 34 felonies in the case. By The New York Times Update on ...

Proud of my fellow Georgetown Football alum Dr. David Fajgenbaum who has dedicated his life to repurposing old drugs to cure rare diseases. This FDA approval is a huge step in the right direction ...

The good news is that there's a simple solution to enable you to try the best VPN apps without locking you into long-term commitment – alas VPN free trials. While pure free trials are generally ...

The Federal Trade Commission’s (FTC) antitrust case against Meta, the parent company of Facebook and Instagram, will head to trial on April 14. U.S. District Judge James Boasberg scheduled a ...

Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control treatment — are simultaneously evaluated in two or more arms of the ...

Amylyx is progressing promising treatments for Wolfram Syndrome and Progressive Supranuclear Palsy with potential phase 3 trials. Learn more on AMLX stock here.

The company's head of development, Martin Lange Holst, told the meeting that the promising results justify further research and a larger phase 2 trial is planned for the second half of this year ...

Negative results from a Huntington’s trial add to a calamitous year for Sage, which last month decided to overhaul its research, reconfigure its executive team and lay off a third of its staff.